Open Cancer Clinical Trials
The University of Chicago Medicine Comprehensive Cancer Center is leading the way in biomedical
discoveries that will help physicians fight cancer more effectively.
Our dedicated researchers and clinicians are conducting clinical trials in phases I, II, III and IV, leading to the development of new and better treatments.
If you are a patient or a caregiver and would like to learn more our cancer clinical trials
call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or
email cancerclinicaltrials@bsd.uchicago.edu .
Phase III
|
Study No
|
PI
|
Title
|
|
|
CIRB14-1502
|
McNeer, Jennifer
|
AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
|
Details
|
True
|
|
CIRB14-1184
|
McNeer, Jennifer
|
COG AALL1231: A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy)
|
Details
|
True
|
|
10-617-A
|
McNeer, Jennifer
|
COG AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
|
Details
|
True
|
Others
|
Study No
|
PI
|
Title
|
|
|
10-586-A
|
McNeer, Jennifer
|
COG AALL08B1 Classification of Newly Diagnosed Acute Lymphoblastic Leukemia
|
Details
|
False
|
|
16070A
|
McNeer, Jennifer
|
A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens
|
Details
|
False
|
Although our objective is to provide on updated listings of clinical trials, please note that a listing here does not guarantee that a trial is open
or available to any specific patient. Additional trials may be available that are not listed. Complete information is available only from a treating
physician.
Are you part of the research staff and cannot see your study listed here? Please contact the cancer center IT Team .
